Wird geladen...
Azithromycin and risk of COPD exacerbations in patients with and without Helicobacter pylori
BACKGROUND: Helicobacter pylori (HP) infection is associated with reduced lung function and systemic inflammation in chronic obstructive pulmonary disease (COPD) patients. Azithromycin (AZ) is active against HP and reduces the risk of COPD exacerbation. We determined whether HP infection status modi...
Gespeichert in:
| Veröffentlicht in: | Respir Res |
|---|---|
| Hauptverfasser: | , , , , , , , , , , , , , , , , |
| Format: | Artigo |
| Sprache: | Inglês |
| Veröffentlicht: |
BioMed Central
2017
|
| Schlagworte: | |
| Online Zugang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5450077/ https://ncbi.nlm.nih.gov/pubmed/28558695 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12931-017-0594-x |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|